Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: TREAD: Time Restricted Eating Intervention for Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating time-restricted eating as an intervention for mild cognitive impairment and Alzheimer's disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: Mild Cognitive Impairment, Alzheimer Disease | Phase 1 | Status: RECRUITING